LAMEA Infertility Drugs Market Size, Share & Trends to 2028

LAMEA Infertility Drugs Market Size, Share & Industry Trends Analysis Report By End User, By Distribution Channel (Hospital Pharmacy, Specialty & Retail Pharmacy, and Online Pharmacy), By Drug Class, By Country and Growth Forecast, 2022 - 2028

Published Date: December-2022 | Number of Pages: 90 | Format: PDF | Report ID: KBV-13036

Special Offering: Industry Insights | Market Trends | Highest number of Tables | 24/7 Analyst Support


Get in-depth analysis of the COVID-19 impact on the LAMEA Infertility Drugs Market

Market Report Description

The Latin America, Middle East and Africa Infertility Drugs Market would witness market growth of 8.8% CAGR during the forecast period (2022-2028).

Hormonal treatment is used during ovulation induction to encourage the release of eggs or ovulation. Historically, these medications were developed to help women who had irregular menstrual periods or who could not ovulate naturally. Creating a single, healthy egg was the aim.

Increased odds of conception were achieved by using ovulation induction to boost the number of eggs maturing in a single cycle. Injectable drugs were the original treatment agents, which were initially employed for in vitro fertilization (IVF) and afterward for less complicated procedures. These medications come with a higher chance of multiple pregnancies, ovarian hyperstimulation, and a higher price tag and time commitment.

Ovulation induction and intrauterine insemination are usually coupled in ovulatory females. Ovulation induction shouldn't proceed until a comprehensive assessment has been completed. Prior to using fertility medications to induce ovulation, hormone problems such as thyroid dysfunction should be addressed.

Nearly 60% of all instances of infertility are attributed to male factors, and 30–50% of these cases are still idiopathic. About 22.6% of males in the area of the Middle East and North Africa (MENA) who are of reproductive age have male infertility. Numerous variables, such as endocrine disruption, exposure to chemicals, lifestyle choices, and genetic and epigenetic changes, contribute to male infertility. Due to the high frequency of male infertility in the MENA area, it is crucial to investigate the effect, as a genetic aberration is a major factor in the pathogenesis of male infertility. As a result, the market for infertility drugs in LAMEA is growing due to the region's increasing infertility cases.

The Brazil market dominated the LAMEA Infertility Drugs Market by Country in 2021; thereby, achieving a market value of $81.3 million by 2028. The Argentina market is showcasing a CAGR of 9.4% during (2022 - 2028). Additionally, The UAE market would register a CAGR of 8.5% during (2022 - 2028).

Based on End User, the market is segmented into Women and Men. Based on Distribution Channel, the market is segmented into Hospital Pharmacy, Specialty & Retail Pharmacy, and Online Pharmacy. Based on Drug Class, the market is segmented into Gonadotropins, Aromatase Inhibitors, Selective Estrogen Receptor Modulators (SERMs), Dopamine Agonists, and Others. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.

Free Valuable Insights: The Worldwide Infertility Drugs Market is Projected to reach USD 4.8 Billion by 2028, at a CAGR of 6.2%

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Abbott Laboratories, Bayer AG, Novartis AG, Merck & Co., Inc., Pfizer, Inc., Teva Pharmaceuticals Industries Ltd., Sanofi S.A., Ferring Holdings SA, Organon & Co. and Mankind Pharma Ltd.

Scope of the Study

Market Segments Covered in the Report:

By End User

  • Women
  • Men

By Distribution Channel

  • Hospital Pharmacy
  • Specialty & Retail Pharmacy
  • Online Pharmacy

By Drug Class

  • Gonadotropins
  • Aromatase Inhibitors
  • Selective Estrogen Receptor Modulators (SERMs)
  • Dopamine Agonists
  • Others

By Country

  • Brazil
  • Argentina
  • UAE
  • Saudi Arabia
  • South Africa
  • Nigeria
  • Rest of LAMEA

Key Market Players

List of Companies Profiled in the Report:

  • Abbott Laboratories
  • Bayer AG
  • Novartis AG
  • Merck & Co., Inc.
  • Pfizer, Inc.
  • Teva Pharmaceuticals Industries Ltd.
  • Sanofi S.A.
  • Ferring Holdings SA
  • Organon & Co.
  • Mankind Pharma Ltd.

Unique Offerings from KBV Research

  • Exhaustive coverage
  • The highest number of market tables and figures
  • Subscription-based model available
  • Guaranteed best price
  • Assured post sales research support with 10% customization free

Related Reports:

Global Infertility Drugs Market Report 2022-2028

North America Infertility Drugs Market Report 2022-2028

Europe Infertility Drugs Market Report 2022-2028

Asia Pacific Infertility Drugs Market Report 2022-2028

Purchase Report


Special Pricing & Discounts

  • Buy Sections of This Report
  • Buy Country Level Reports
  • Request for Historical Data
  • Discounts Available for Start-Ups & Universities